PubRank

T G Johns

Author PubWeight™ 16.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. Cancer Res 2001 1.52
2 Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Res 2001 1.47
3 Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med (Berl) 1997 1.41
4 Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int 1992 1.18
5 The regulation of mitochondrial DNA copy number in glioblastoma cells. Cell Death Differ 2013 1.09
6 Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol 2006 1.07
7 Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. Br J Cancer 2005 0.93
8 The pharmacological profile of a potential hypnotic compound RU 31158. Arch Int Pharmacodyn Ther 1979 0.92
9 In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs. Br J Cancer 2008 0.91
10 Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int Immunol 1996 0.90
11 Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev Neurosci 1997 0.88
12 Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 1996 0.86
13 Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem Mol Biol Int 1993 0.79
14 Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series. Hum Reprod 2014 0.78
15 Automated analysis of sleep in the rat. Electroencephalogr Clin Neurophysiol 1977 0.76
16 Proceedings: A technique for the quantitative characterization of the sleep-wake cycle in the rat. Br J Pharmacol 1974 0.75
17 Amino acid substitutions alter the tissue distribution of murine interferon-alpha 1. J Interferon Res 1993 0.75
18 Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells. Biochem Int 1990 0.75
19 Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes. Nat Immun 1992 0.75